CAR - T Daaweynta unugyada, CAR T Therapy, GARGAARKA GARGAARKA, wakiilka chimeric
U Quus Qoto dheer ee CAR T Therapy: Sidee bay u shaqeysaa?
Soo hel sayniska ka dambeeya CAR T daawaynta unug ee Hindiya! Sahami sida daawayntan kacaanka ahi ay ugu beddesho unugyada difaaca jidhka dagaalyahannada kansarka. Akhri blog-keena hadda si aad wax badan uga ogaato daawayntan mucjisada ah iyo sida ..
CAR - T Daaweynta unugyada, GARGAARKA GARGAARKA, Soo -dhaweeyaha Wakiilka Chimeric, Korea, Seoul, South Korea
Shirkadaha Kuuriya waxay qaadaan tallaabo ku dhow horumarinta daaweynta guriga ee CAR T-Cell
May 2023: Chimeric antigen reseptor (CAR) daawaynta unugyada T-unuga waa horumar cusub oo dhinaca daawaynta kansarka shaqsiyeed. Unugyada T-yada bukaanka ayaa si hidde ahaan wax looga beddelay inta lagu jiro habka wax soo saarka si loo muujiyo a.
bayotechnoolajiyadda, CAR - T Daaweynta unugyada, GARGAARKA GARGAARKA, Daaweynta CAR, Shiinaha, lacag ururin, Oricell Therapeutics
Oricell waxa uu kor u qaadaa $45M USD si uu ugu balaadhiyo daawaynta CAR T-Cell ee Maraykanka
23-ka Maarso 2023: Daawaynta unugyada kansarka ee hore iyo heerka hore ee ay samaysay Shanghai biotech Oricell waxay heshay $45 milyan oo dheeri ah oo maalgelin ah, shirkaddu waxay ku dhawaaqday Talaadadii. Ka dib bandhiga AS..
Australia, CAR - T Daaweynta unugyada, CAR T Therapy, Cartherics
Xarunta Kansarka ee Peter MacCallum iyo Cartherics waxay iska kaashan doonaan kansarka ugxan-sidaha daawaynta unugga CAR-T
Maarso 2023: Xarunta Kansarka ee Peter MacCallum (Peter Mac) ee Australia iyo Cartherics Pty Ltd waxay galeen heshiis barnaamijka horumarinta iskaashiga ah (CDPA) si ay u horumariyaan CTH-002 ee daaweynta kansarka ugxansidaha. cli..
CAR - T Daaweynta unugyada, GARGAARKA GARGAARKA, Emily Littlejohn, Immunology, dib u soo kabashada lupus
Daawaynta cusub ee CAR T-Cell ee dib u soo kabashada lupus
Feb 2024: Dhawr daawo oo cusub iyo daawayn rajo leh, sida chimeric antigen receptor T-cell therapy, ayaa keenay "dib u soo noolaynta" lupus, sida laga soo xigtay af-hayeenka doodaha aasaasiga ah iyo Immunology Clinical for the Busy ..
anti-BCMA, CAR - T Daaweynta unugyada, CT103A, FDA, IASO Biotherapeutics, Bayooloji cusub, agoonta magacaabista daroogada
CT103A, CAR T-cell Therapy, waxaa FDA u qoondaysay sidii daawo agoon ah.
Feb 2023: The FDA has granted orphan drug status to CT103A, an experimental CAR T-cell therapy being developed by IASO Biotherapeutics and Innovent Biologics to treat relapsed or refractory multiple myeloma. Orphan drug design..
CAR - T Daaweynta unugyada, Shiinaha, IASO Biotherapeutics, Meelo badan
Daaweynta CAR T-cell ee IASO Biotherapeutics waxay heshaa oggolaan cusub oo FDA ah
Feb 2023: IASO Biotherapeutics 'daawaynta CAR T-cell ee baadhista soo noqnoqda ama dib u celinta multi myeloma (RRMM), CT103A, waxay ka heshay daawaynta degdega ah iyo dib u soo kabashada daawaynta horumarsan ee cuntada Maraykanka iyo
CAR - T Daaweynta unugyada, Seoul, South Korea
AMC waxay ka furtay xarunta daaweynta CAR T-Cell ee Seoul
Jan 2023: Xarunta Caafimaadka ee Asan (AMC) ayaa furtay xaruntii ugu horreysay ee daawaynta unugga CAR-T ee dalka ka dib markii ay dawladdu oggolaatay faa'iidooyinka caymiska caafimaadka ee Kymriah's CAR-T cell therapy.AMC ayaa Talaadadii ku dhawaaqday in ay awood u leedahay.
Tijaabada Dhiiga, CAR - T Daaweynta unugyada, JAMA Onkoloji, silsilad iftiin neurofilament, Dhibaatooyinka Neurotoxic, Jaamacadda Washington
CAR T-Cell dhibaatooyinka daawaynta waxaa lagu saadaalin karaa baaritaan dhiig oo fudud
Sebtembar 2022: Daawaynta burooyin kala duwan ayaa lagu beddelay immunotherapy-ku-saleysan unug, oo badanaa loo yaqaan daawaynta unugyada CAR-T. Si loola dagaallamo noocyada gaarka ah ee leukemia iyo lymphoma, daaweyntu waxay shaqaaleysiisaa hidde-side.
CAR - T Daaweynta unugyada, Hal qayb oo ka mid ah CARsgen Therapeutics Co., Ltd, Shirkadda Daiichi Sankyo, DLBCL, Cilmi-baadhis degdeg ah, Xaddidan, Novartis AG
CAR T-Cell therapy suuqa ayaa ku kori doona heer cajiib ah 8 sano ee soo socota
Luulyo 2022: Marka loo eego cilmi-baaristii ugu dambeysay ee ay sameysay Cilmi-baarista Emergen, suuqa adduunka ee daaweynta unugyada CAR T-cells wuxuu gaaray cabbir dhan USD 1.29 bilyan sanadka 2021 waxaana la filayaa inuu diiwaangeliyo dakhli CAGR ah 24.9 boqolkiiba ..